HOME >> BIOLOGY >> NEWS
Penn study finds inhaled anesthetics accelerate the appearance of brain plaque in animals

PHILADELPHIA Researchers at the University of Pennsylvania's School of Medicine have discovered that common inhaled anesthetics increase the number of amyloid plaques in the brains of animals, which might accelerate the onset of neurodegenerative diseases like Alzheimer's. Roderic Eckenhoff, MD, Vice Chair of Research in the University of Pennsylvania's Department of Anesthesia and Critical Care, and his co-authors, report their findings in the March 7th online edition of Neurobiology of Aging.

Every year over 100 million people undergo surgery worldwide, most under general anesthesia with an inhaled drug. These drugs clearly affect cognitive ability at least in the short term, but the growing concern is that inhaled anesthetics may affect a person well beyond the perioperative period, even permanently. Several factors appear to play a role in this subtle loss of cognitive ability, most notably age.

A specific effect of these drugs on dementias like Alzheimer's disease, though suspected for many years, has only been recently supported by data. In 2003, Eckenhoff's group showed that the inhaled anesthetics enhance the aggregation and cytotoxicity of the amyloid beta peptide. Just last month, a study reported that these drugs also enhance the production of amyloid beta in isolated cells. But these protein and cell culture studies are a long way from showing that an effect occurs in vivo. This new study provides the first evidence that the predicted effect occurs in animals.

"This animal study data suggests that we have to at least consider the possibility that anesthetics accelerate certain neurodegenerative disorders," said Eckenhoff. "In the field of Alzheimer's research, most effort is focused on delaying, not curing the disease. A delay in the onset of Alzheimer's disease of only three to five years would be considered a success. Therefore, if commonly used drugs, like anesthetics, are accelerating this disorder, even by a few years, then a
'"/>

Contact: Rick Cushman
rick.cushman@uphs.upenn.edu
215-349-5659
University of Pennsylvania School of Medicine
9-Mar-2007


Page: 1 2

Related biology news :

1. New study warns limited carbon market puts 20 percent of tropical forest at risk
2. Clones on task serve greater good, evolutionary study shows
3. Pollution causes 40 percent of deaths worldwide, study finds
4. A study by the MUHC and McGill University opens a new door to understanding cancer
5. New study suggests Concord grape juice may provide protection against breast cancer
6. Preclinical study links gene to brain aneurysm formation
7. In limiting life span, study finds booming bacteria innocent
8. Multicenter study nets new lung tumor-suppressor gene
9. MIT study: Maturity brings richer memories
10. Chickadee, nutchatch presence in conifers increases tree growth, says CU-Boulder study
11. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/7/2020)... ... January 06, 2020 , ... Myant Inc. , the pioneers in Textile ... bring to life its vision of a world where textile-based interfaces knitted into everyday ... digital sphere, and the physical IoT-enabled environment. The experience at Myant’s booth will challenge ...
(Date:12/30/2019)... ... 30, 2019 , ... Cure Now ? Instead of Palliative ... is the 6th leading cause of death in the United States. , ... other dementia. ,     These caregivers provided an estimated 18.5 billion hours of ...
(Date:12/21/2019)... ... ... The City of Tampa recently served as the host location of the ... Tampa welcomed these most-highly decorated USA heroes as the National Hockey League (NHL), The ... members. , The Medal of Honor, the USA military’s highest award for valor in ...
Breaking Biology News(10 mins):
(Date:12/18/2019)... , ... December 17, 2019 , ... ... its 31st FDA clearance for reprocessing Electrophysiology (EP) devices since the company’s inception ... Stryker Sustainability Solutions and SterilMed (a Johnson & Johnson company) have received 2 ...
(Date:12/18/2019)... ... 18, 2019 , ... Tune in to CNBC on Saturday, December 28th at ... listings for more information on this program. , With a look at Avatar ... complex system to increase the efficiency, safety and effectiveness of equipment, systems, and processes ...
(Date:12/6/2019)... ... December 06, 2019 , ... ... clearance for its latest CAPERE® Thrombectomy System for peripheral vascular, deep vein ... great benefits for first-in-line treatment for nonsurgical removal of soft emboli and ...
(Date:12/4/2019)... ... December 03, 2019 , ... ... today announced a partnership with the Recombinant Antibody Network (RAN), a consortium of ... San Francisco (UCSF) with a common goal to generate recombinant antibodies at a ...
Breaking Biology Technology:
Cached News: